Skip to main content
Clinical Trials/NCT04040842
NCT04040842
Recruiting
Not Applicable

Quality and Outcomes in Global Cancer Surgery: a Prospective, International Cohort Study Evaluating Low Anterior Resection Syndrome (LARS)

National Cancer Institute, Lithuania1 site in 1 country400 target enrollmentSeptember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Anterior Resection Syndrome
Sponsor
National Cancer Institute, Lithuania
Enrollment
400
Locations
1
Primary Endpoint
LARS score change comparing before surgery and 1 year after the surgery.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

  • Aim: The aim of this study is to perform a prospective, international 4 months cohort study evaluating bowel function before curative rectal cancer surgery and one year after the surgery using the LARS score.
  • Primary outcome measure: LARS score before surgery and 1 year after the surgery.
  • Primary comparison: Between average LARS score before and after curative surgery and also comparing these with publish LARS score on normal population.

Detailed Description

All patients undergoing treatment for rectal rectal will be included in the study. Before any treatment all the included patients will be asked to fill the LARS score (5 question questionnaire with differently weighted answers for assessing the low anterior resection score). One year after the low anterior resection (without the stoma) or following the stoma take down patients will be reassessed. The LARS score will be filled one again. Patient characteristics, age, cancer stage, level of anastomosis will be assessed aswel.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
National Cancer Institute, Lithuania
Responsible Party
Principal Investigator
Principal Investigator

Audrius Dulskas

Assoc. professor

National Cancer Institute, Lithuania

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing rectal cancer surgery on curative intent.
  • Elective surgery patients.
  • Laparoscopic, laparoscopic-converted, robotic, TaTME (transanal total mesorectal excision) and open cases will be included.
  • Patients aged 18 years and over should be included.

Exclusion Criteria

  • Patients undergoing a procedure purely for diagnosis or staging should be excluded.
  • Patients with palliative treatment.
  • Patients with recurrence should be excluded.
  • Patients with dementia
  • Patients who do not complete their treatment within 12 months of primary surgery e.g. including reversal of stoma, chemotherapy etc

Outcomes

Primary Outcomes

LARS score change comparing before surgery and 1 year after the surgery.

Time Frame: 12 months

Low anterior resection score is a simple questionnaire consisting of five simple questions for bowel function assessment after anterior resection. The maximum number is between 0 and 42. No LARS (good bowel function) is from 0 to 20; minor LARS - 21-29 and major LARS (poor bowel function) more than 29. Between average LARS score before and after curative surgery and also comparing these with published LARS score on normal population.

Study Sites (1)

Loading locations...

Similar Trials